{"id":522051,"date":"2021-08-03T08:04:03","date_gmt":"2021-08-03T12:04:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/"},"modified":"2021-08-03T08:04:03","modified_gmt":"2021-08-03T12:04:03","slug":"magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/","title":{"rendered":"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August <\/b><\/p>\n<p>CAMBRIDGE, Mass.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nMagenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that the company will participate in the following August investor conferences:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nBTIG Virtual Biotechnology Conference, presentation at 12:00 p.m. ET on Monday, August 9\n<\/li>\n<li>\n2021 Wedbush PacGrow Healthcare Virtual Conference, panel: So Let it Be (Re)Written &#8211; Updates in Gene Modulation at 9:10 a.m. ET on Tuesday, August 10\n<\/li>\n<\/ul>\n<p>\nAdditional information can be found on the Magenta Therapeutics website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestor.magentatx.com%2Fevents-and-presentations&amp;esheet=52470370&amp;newsitemid=20210803005378&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestor.magentatx.com%2Fevents-and-presentations&amp;index=1&amp;md5=ff35a95270073cd8c83ded075c365a25\">https:\/\/investor.magentatx.com\/events-and-presentations<\/a>.\n<\/p>\n<p><b>About Magenta Therapeutics <\/b><\/p>\n<p>\nMagenta Therapeutics is a clinical-stage biotechnology company developing medicines designed to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.\n<\/p>\n<p>\nMagenta is based in Cambridge, Mass. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.magentatx.com&amp;esheet=52470370&amp;newsitemid=20210803005378&amp;lan=en-US&amp;anchor=www.magentatx.com&amp;index=2&amp;md5=452da4ac006bc29d5629eacd729c76d9\">www.magentatx.com<\/a>.\n<\/p>\n<p>\nFollow Magenta on Twitter: @magentatx.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210803005378\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210803005378\/en\/<\/a><\/span><\/p>\n<p>\nLyndsey Scull, Director, Corporate Communications<br \/>\n<br \/>202-213-7086<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:lscull@magentatx.com\">lscull@magentatx.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Massachusetts<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Genetics Stem Cells Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210803005378\/en\/817767\/3\/Magenta_logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that the company will participate in the following August investor conferences: BTIG Virtual Biotechnology Conference, presentation at 12:00 p.m. ET on Monday, August 9 2021 Wedbush PacGrow Healthcare Virtual Conference, panel: So Let it Be (Re)Written &#8211; Updates in Gene Modulation at 9:10 a.m. ET on Tuesday, August 10 Additional information can be found on the Magenta Therapeutics website at https:\/\/investor.magentatx.com\/events-and-presentations. About Magenta Therapeutics Magenta Therapeutics is a clinical-stage biotechnology company developing medicines designed to bring the curative power of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-522051","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that the company will participate in the following August investor conferences: BTIG Virtual Biotechnology Conference, presentation at 12:00 p.m. ET on Monday, August 9 2021 Wedbush PacGrow Healthcare Virtual Conference, panel: So Let it Be (Re)Written &#8211; Updates in Gene Modulation at 9:10 a.m. ET on Tuesday, August 10 Additional information can be found on the Magenta Therapeutics website at https:\/\/investor.magentatx.com\/events-and-presentations. About Magenta Therapeutics Magenta Therapeutics is a clinical-stage biotechnology company developing medicines designed to bring the curative power of &hellip; Continue reading &quot;Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-03T12:04:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August\",\"datePublished\":\"2021-08-03T12:04:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/\"},\"wordCount\":244,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/\",\"name\":\"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-08-03T12:04:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/","og_locale":"en_US","og_type":"article","og_title":"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August - Market Newsdesk","og_description":"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211; Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that the company will participate in the following August investor conferences: BTIG Virtual Biotechnology Conference, presentation at 12:00 p.m. ET on Monday, August 9 2021 Wedbush PacGrow Healthcare Virtual Conference, panel: So Let it Be (Re)Written &#8211; Updates in Gene Modulation at 9:10 a.m. ET on Tuesday, August 10 Additional information can be found on the Magenta Therapeutics website at https:\/\/investor.magentatx.com\/events-and-presentations. About Magenta Therapeutics Magenta Therapeutics is a clinical-stage biotechnology company developing medicines designed to bring the curative power of &hellip; Continue reading \"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-03T12:04:03+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August","datePublished":"2021-08-03T12:04:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/"},"wordCount":244,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/","name":"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-08-03T12:04:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210803005378r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/magenta-therapeutics-to-participate-in-upcoming-healthcare-investor-conferences-in-august\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=522051"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522051\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=522051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=522051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=522051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}